Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Buy
29,935
+101
+0.3% +$11.1K 0.07% 217
2026
Q1
$3.14M Sell
29,834
-4,484
-13% -$527K 0.08% 215
2025
Q4
$4.28M Buy
34,318
+13,364
+64% +$1.59M 0.1% 170
2025
Q3
$2.51M Sell
20,954
-231
-1% -$24.4K 0.06% 276
2025
Q2
$1.94M Sell
21,185
-2,854
-12% -$260K 0.05% 319
2025
Q1
$2.11M Buy
24,039
+2,506
+12% +$246K 0.06% 300
2024
Q4
$1.99M Sell
21,533
-239
-1% -$23K 0.06% 279
2024
Q3
$2.02M Sell
21,772
-3,062
-12% -$257K 0.06% 277
2024
Q2
$1.86M Buy
24,834
+4,047
+19% +$323K 0.06% 265
2024
Q1
$1.79M Sell
20,787
-5,762
-22% -$440K 0.07% 276
2023
Q4
$1.83M Buy
26,549
+1,766
+7% +$107K 0.07% 256
2023
Q3
$1.37M Buy
+24,783
New +$1.41M 0.07% 306

Other funds holding CRH

Metis Global Partners's CRH Position: Q2 2026 in Review

Metis Global Partners increased its CRH (CRH) stake by 0.34% in Q2 2026, buying an estimated $11.1K and bringing the position to 29,935 shares worth $3.2M. The position accounts for 0.07% of the portfolio, ranked #217.

Metis Global Partners first reported a position in CRH in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.28M in Q4 2025. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Metis Global Partners held 29,935 shares of CRH worth $3.2M as of Q2 2026.
  • Metis Global Partners bought 101 CRH shares in Q2 2026, an estimated $11.1K.
  • CRH made up 0.07% of Metis Global Partners's portfolio in Q2 2026, its #217 holding.
  • Metis Global Partners first reported a position in CRH in Q3 2023 and has held it in 12 quarters since.
  • Metis Global Partners's CRH position peaked at $4.28M in Q4 2025.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.